-
PA-824: A Bicyclic Nitroimidazole for TB Research
2026-09-21
PA-824 is a high-potency tuberculosis research compound for probing cell-wall biosynthesis, nitric oxide release, and respiratory vulnerability in Mycobacterium tuberculosis. This practical guide converts its dual-action biology into reproducible susceptibility, persistence, and combination-assay workflows, with troubleshooting for solubility, controls, and signal interpretation.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-09-21
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve handling of poorly water-soluble hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. It is appropriate as a drug formulation excipient and solubility-enhancement reagent in pharmaceutical or biochemical workflows, but the supplied record does not establish therapeutic efficacy or unrelated applications.
-
Homoharringtonine: Assay Design from Ribosome to Virus
2026-09-20
Homoharringtonine is a cytotoxic alkaloid whose ribosome-targeting activity connects leukemia research with SARS-CoV-2 antiviral research. This guide focuses on assay architecture, endpoint selection, and the practical limits of translating protein-synthesis inhibition across disease models.
-
Caspase-4 Colorimetric Assay Kit: Practical Guide
2026-09-19
Turn pyroptosis and inflammatory signaling questions into quantitative LEVD-dependent caspase-4 measurements with a rapid colorimetric workflow. This guide connects the assay to ER-stress cancer models while emphasizing controls, normalization, and interpretation limits.
-
Coumestrol Drives PMAIP1-Linked Ferroptosis in RA
2026-09-18
The reference study identifies a mechanistic link between Coumestrol, TRIM3-regulated PMAIP1 stability, mitochondrial stress, and ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. Its in vitro findings suggest a way to suppress pathological synoviocyte proliferation and cytokine production, while also defining important limits for translation beyond cell culture.
-
EGCG as a Translational Antiangiogenic Strategy
2026-09-18
(-)-Epigallocatechin gallate (EGCG) offers a mechanistically rich platform for connecting angiogenesis, inflammation, adhesion, apoptosis, and tumorigenesis research. This article translates findings from an anti-inflammatory airway-stent study into a disciplined strategy for validating EGCG in local-delivery, cancer chemoprevention, and antiviral research without overstating the current evidence.
-
TCEP Hydrochloride for Reductive Assay Workflows
2026-09-17
TCEP hydrochloride brings odorless, water-soluble disulfide reduction to protein preparation, proteomics, and antibody-conjugation workflows. This practical guide also shows how controlled reductive chemistry can support capture-and-release lateral flow assay development without overstating what has been demonstrated in the reference study.
-
In Vitro Drug Response: Viability, Growth, and Death
2026-09-17
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer response. Its central contribution is a framework for separating proliferative arrest from cell killing, improving interpretation of dose–response experiments and the timing of drug effects.
-
Transcription Condensates Safeguard Genome Stability
2026-09-16
A 2026 Molecular Cell study shows that transcription condensates at histone locus bodies are formed at the G1/S transition and actively dissolved during mid-S phase by the ATR–CHK1 checkpoint. This kinase-timed switch limits linker histone H1.1 expression and prevents replication-associated DNA damage, providing a mechanistic framework for coordinating transcription with genome duplication.
-
From m6A Sensitivity to Smarter Protein Immunoblots
2026-09-16
Translational research increasingly depends on connecting molecular measurements across assay classes. This article examines what amplification-free m6A detection teaches us about sensitivity, then shows how hypersensitive HRP-based immunoblotting can strengthen downstream protein validation without confusing RNA-level discovery with protein-level evidence.
-
Colistin–Gamithromycin Synergy in P. multocida
2026-09-15
This study shows that colistin and gamithromycin can produce isolate-dependent synergy against Pasteurella multocida, including substantially lower concentrations and improved activity in a neutropenic murine lung infection model. Its integrated susceptibility, time-kill, pharmacokinetic, and pharmacodynamic design provides a useful framework for evaluating antibiotic combinations beyond single-drug MIC testing.
-
Imipenem Workflows for Resistance Research
2026-09-15
Imipenem supports more than routine susceptibility testing: it can anchor workflows spanning PBP-directed antibacterial research, carbapenemase transmission analysis, immune response modulation, and sepsis animal model design. This guide connects product handling with practical assay controls, resistance-genotype interpretation, and troubleshooting strategies.
-
AZ505: A Substrate-First SMYD2 Assay Framework
2026-09-14
AZ505 is a substrate-competitive SMYD2 inhibitor for dissecting methyltransferase-dependent biology. This article develops a context-aware assay framework linking binding mode, renal fibrosis evidence, and cancer biology research without confusing biochemical potency with cellular mechanism.
-
7ACC2: Monocarboxylate Transporter 1 Inhibitor Workflows
2026-09-14
7ACC2 enables controlled interrogation of lactate uptake, pyruvate flux, and metabolic stress in cancer models. This practical guide connects transporter assays with the CH25H–25-hydroxycholesterol macrophage pathway while clearly separating established product evidence from testable experimental hypotheses.
-
PPARγ Activation in DSS-Induced Inflammatory Bowel Disease
2026-09-13
This study shows that pioglitazone-mediated PPARγ activation shifts macrophage responses away from inflammatory M1 polarization toward reparative M2 features through coordinated STAT-1/STAT-6 signaling. In a DSS-induced mouse model and RAW264.7 cell systems, this pathway-level intervention improved clinical, histological, and intestinal barrier outcomes, while also defining important limits for translation.